Robert J. Gould - Jun 27, 2023 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Interim President & CEO, Director
Signature
/s/ Greg Tourangeau, as attorney-in-fact for Robert J. Gould
Stock symbol
FULC
Transactions as of
Jun 27, 2023
Transactions value $
$0
Form type
4
Date filed
6/29/2023, 04:16 PM
Previous filing
Jan 13, 2023
Next filing
Jul 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +30K $0.00 30K Jun 27, 2023 Common Stock 30K $3.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 27, 2023 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.